Literature DB >> 8636829

Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine.

A Ravelli1, F De Benedetti, S Viola, A Martini.   

Abstract

A macrophage activation syndrome, possibly related to methotrexate toxicity, developed in a boy with systemic juvenile rheumatoid arthritis. Corticosteroid administration was ineffective, whereas a prompt response to cyclosporine was observed. Two months later, Pneumocystis carinii pneumonia developed.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8636829     DOI： 10.1016/s0022-3476(96)70408-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  34 in total

Review 1.  [The treatment of juvenile rheumatism: pharmacotherapy].

Authors:  F Weller; H-I Huppertz
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

2.  Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.

Authors:  Lehn K Weaver; Edward M Behrens
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-02-07

3.  Association of Macrophage Activating Syndrome with Castleman's Syndrome in Systemic Lupus Erythematosus.

Authors:  Shamsa Shariatpanahi; Shahryar Pourfarzam; Mohammadhosein Gheini
Journal:  Iran J Pathol       Date:  2016

Review 4.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

Review 5.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan Dewitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

6.  Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis.

Authors:  Mina Hur; Young Chul Kim; Kyu Man Lee; Kwang Nam Kim
Journal:  J Korean Med Sci       Date:  2005-08       Impact factor: 2.153

7.  2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.

Authors:  Sarah Ringold; Pamela F Weiss; Timothy Beukelman; Esi Morgan DeWitt; Norman T Ilowite; Yukiko Kimura; Ronald M Laxer; Daniel J Lovell; Peter A Nigrovic; Angela Byun Robinson; Richard K Vehe
Journal:  Arthritis Rheum       Date:  2013-10

8.  Macrophage activation syndrome in juvenile rheumatoid arthritis successfully treated with cyclosporine A: a case report.

Authors:  Chan-Ran You; Hae-Rim Kim; Chong-Hyeon Yoon; Sang-Heon Lee; Sung-Hwan Park; Ho-Youn Kim
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

9.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

Review 10.  Macrophage Activation Syndrome.

Authors:  Ethan S Sen; Sarah L N Clarke; Athimalaipet V Ramanan
Journal:  Indian J Pediatr       Date:  2015-09-24       Impact factor: 1.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.